Resources
56 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 12/3/2019 (updated 9/2/2021)
SBIRT is an integrated, public health approach to the delivery of early intervention and treatment services for persons with substance use disorders and those at risk of developing these disorders.
Posted 6/12/2020 (updated 9/2/2021)
Mother & Baby Substance Exposure Toolkit Best Practices All Best Practices came as a part of the California Medication Assisted Treatment Expansion Project
Posted 5/22/2020 (updated 9/2/2021)
To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.
Posted 6/15/2020 (updated 9/2/2021)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 6/30/2020 (updated 9/2/2021)
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
Posted 10/12/2020 (updated 9/2/2021)
This resource provides a summary of HIV risk assessment, screening tests, screening intervals, and treatment and interventions for both adolescents and adults and pregnant persons.
Posted 10/13/2020 (updated 9/2/2021)
This e-book was designed to empower patients with opioid use disorder who will be having surgery.
Posted 12/2/2020 (updated 9/2/2021)
This Association of Maternal & Child Health Programs (AMCHP) issue brief discusses the challenges and opportunities in providing rural community care to women with mental health and substance use treatment needs.
Posted 12/15/2020 (updated 9/2/2021)
This workshop presented strategies to integrate HIV, hepatitis, and sexual health concerns into services for PWID. The session focused on communication skills, assessment techniques, and building motivation to make healthier choices. The presentation looked at programmatic and clinical level integration strategies and offered participants a chance to assess current service delivery models and develop a plan to enhance care.
Posted 1/20/2021 (updated 9/2/2021)
People who use drugs (PWUD) in the U.S. experience disproportionate adverse health outcomes and mortality as compared with the population as a whole (Lake & Kennedy, 2016; Reisinger, Pratt, Shoenborn, & Druss, 2017). Similar health outcomes have been reported elsewhere, for example in the UK (Neale, 2004), and across 8 other European countries (Bargagli et al., 2006). In the U.S. health outcomes among PWUD are intensified by the overdose pandemic, epidemic rates of HIV, hepatitis A and C, skin and soft tissue infections (CDC Centers for Disease Control and Prevention, 2020; Hagen, Thiede, & Des Jarlais, 2005; Scholl, Seth, Kariisa, Wilson, & Baldwin, 2019), and by structural barriers thwarting health access and utilization.